Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Hauser, Belinda ^a   Zhao, Yuan ^a   Pang, Xiaowu ^a   Ling, Zhiqiang ^b   Myers, Ernest ^a   Wang, Paul ^a,c   Califano, Joseph ^d   Gu, Xinbin ^a,c  

^a HOWARD UNIVERSITY   (United States)

^b ZHEJIANG CANCER HOSPITAL   (China)

^c HOWARD UNIVERSITY CANCER CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; LENTIVIRUS VECTOR; MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 128; PROTEIN BAG 2; PROTEIN BAX; PROTEIN H3F3B; PROTEIN PAIP2; UNCLASSIFIED DRUG; BAG2 PROTEIN, HUMAN; BAX PROTEIN, HUMAN; BMI1 PROTEIN, HUMAN; CHAPERONE; MIRN128 MICRORNA, HUMAN; PAIP2 PROTEIN, HUMAN; REPRESSOR PROTEIN; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE FUNCTION; GENE TARGETING; GENETIC ANALYSIS; GROWTH REGULATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; JHU 13 CELL LINE; JHU 22 CELL LINE; LUCIFERASE ASSAY; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE TRANSFECTION; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CANCER TRANSPLANTATION; CELL PROLIFERATION; GENETICS; HEAD AND NECK TUMOR; NUDE MOUSE; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICE; MICE, NUDE; MICRORNAS; MOLECULAR CHAPERONES; NEOPLASM TRANSPLANTATION; POLYCOMB REPRESSIVE COMPLEX 1; REPRESSOR PROTEINS; RNA-BINDING PROTEINS;

EID: 84928905820     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116321     Document Type: Article

References (38)

1. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, et al. (2003) BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95: 625-627. PMID: 12697856
2. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. Ca Cancer J Clin 55: 74-108. PMID: 15761078
3. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics, 2007. Ca Cancer J Clin 57: 43-66. PMID: 17237035
4. Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345: 1890-1900. PMID: 11756581
5. Lippman SM, Sudbo J, Hong WK (2005) Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 23: 346-356. PMID: 15637397
6. Wangpermtam P, Sanguansin S, Petmitr S, Punyarit P, Weerapradist W (2011) Genetic alteration in oral squamous cell carcinoma detected by arbitrarily primed polymerase chain reaction. Asian Pac J Cancer Prev 12: 2081-2085. PMID: 22292655
7. Rapidis AD, Wolf GT (2009) Immunotherapy of head and neck cancer: current and future considerations. J Oncol 2009: 346345. doi: 10.1155/2009/346345 PMID: 19680453
8. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. cell 116: 281-297. PMID: 14744438
9. Singer G, Oldt R 3rd, Cohen Y, Wang BG, Sidransky D, et al. (2003) Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 95: 484-486. PMID: 12644542
10. Bartels CL, Tsongalis GJ (2009) MicroRNAs: novel biomarkers for human cancer. Clin Chem 55: 623-631. doi: 10.1373/clinchem.2008.112805 PMID: 19246618
11. Calin GA, Croce CM (2006) MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66: 7390-7394. PMID: 16885332
12. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, et al. (2008) MicroRNA signature predicts survival and relapse in lung cancer. cancer Cell 13: 48-57. doi: 10.1016/j.ccr.2007.12.008 PMID: 18167339
13. Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23: 175-205. PMID: 17506695
14. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531. PMID: 15211354
15. Tran N, O'Brien CJ, Clark J, Rose B (2010) Potential role of micro-RNAs in head and neck tumorigenesis. Head Neck 32: 1099-1111. doi: 10.1002/hed.21356 PMID: 20213828
16. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, et al. (2010) Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16: 1129-1139. doi: 10.1158/1078-0432.CCR-09-2166 PMID: 20145181
17. Adlakha YK, Saini N (2011) MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells. Cell Mol Life Sci 68: 1415-1428. doi: 10.1007/s00018-010-0528-y PMID: 20924637
18. Khan AP, Poisson LM, Bhat VB, Fermin D, Zhao R, et al. (2010) Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer. Mol Cell Proteomics 9: 298-312. doi: 10.1074/mcp.M900159-MCP200 PMID: 19955085
19. Cui JG, Zhao Y, Sethi P, Li YY, Mahta A, et al. (2010) Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation. J Neurooncol 98: 297-304. doi: 10.1007/s11060-009-0077-0 PMID: 19941032
20. Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, et al. (2008) MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123: 2791-2797. doi: 10.1002/ijc.23831 PMID: 18798260
21. Hao Y, Xie T, Korotcov A, Zhou Y, Pang X, et al. (2009) Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways. Int J Cancer 124: 2200-2209. doi: 10.1002/ijc.24160 PMID: 19123475
22. Zhao Y, Hao Y, Ji H, Fang Y, Guo Y, et al. (2010) Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo. Cancer Prev Res (Phila) 3: 787-796. doi: 10.1158/1940-6207.CAPR-09-0243 PMID: 20501859
23. Noren Hooten N, Abdelmohsen K, Gorospe M, Ejiogu N, Zonderman AB, et al. (2010) microRNA expression patterns reveal differential expression of target genes with age. PLos one 5: e10724. doi: 10.1371/journal.pone.0010724 PMID: 20505758
24. Hu J, Cheng Y, Li Y, Jin Z, Pan Y, et al. (2014) microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. Eur J Cancer 50: 2336-2350. doi: 10.1016/j.ejca.2014.06.005 PMID: 25001183
25. Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, et al. (2010) Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 70: 367-377. doi: 10.1158/0008-5472.CAN-09-1891 PMID: 20028871
26. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, et al. (2008) Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125-9130. doi: 10.1158/0008-5472.CAN-08-2629 PMID: 19010882
27. Evangelisti C, Florian MC, Massimi I, Dominici C, Giannini G, et al. (2009) MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J 23: 4276-4287. doi: 10.1096/fj.09-134965 PMID: 19713529
28. Lessard J, Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423: 255-260. PMID: 12714970
29. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R (2005) Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 19: 1432-1437. PMID: 15964994
30. Ahmad K, Henikoff S (2002) The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol Cell 9: 1191-1200. PMID: 12086617
31. Daury L, Chailleux C, Bonvallet J, Trouche D (2006) Histone H3.3 deposition at E2F-regulated genes is linked to transcription. EMBO Rep 7: 66-71. PMID: 16258499
32. Voncken JW, Schweizer D, Aagaard L, Sattler L, Jantsch MF, et al. (1999) Chromatin-association of the Polycomb group protein BMI1 is cell cycle-regulated and correlates with its phosphorylation status. J Cell Sci 112 (Pt 24): 4627-4639. PMID: 10574711
33. Bartek J, Lukas J (2001) Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol 13: 738-747. PMID: 11698191
34. Karim MM, Svitkin YV, Kahvejian A, De Crescenzo G, Costa-Mattioli M, et al. (2006) A mechanism of translational repression by competition of Paip2 with eIF4G for poly(A) binding protein (PABP) binding. Proc Natl Acad Sci U S A 103: 9494-9499. PMID: 16772376
35. Farnebo L, Jedlinski A, Ansell A, Vainikka L, Thunell LK, et al. (2009) Proteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell lines. Int J Mol Med 24: 549-556. PMID: 19724896
36. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. cell 74: 609-619. PMID: 8358790
37. Shi Y, Chen J, Weng C, Chen R, Zheng Y, et al. (2003) Identification of the protein-protein contact site and interaction mode of human VDAC1 with Bcl-2 family proteins. Biochem. Biophys Res Commun 305: 989-996. PMID: 12767928
38. Adlakha YK aSN (2013) miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis. Cell Death & Disease 4.